Granted Patent
B2
US 7,585,655 · App. 12/274,500 · Granted Sep 8, 2009
Nucleic acid encoding a fusion protein incorporating a cysteinized ribonuclease
Assignee:
Alfacell Corporation
View Patent ↗
Loading inventors, assignments & file history…
Abstract
A nucleic acid encodes a novel fusion protein. The fusion protein contains a cysteinized variant of an RNase disclosed in U.S. Pat. No. 6,239,257 B1.
Claims (2)
1. An isolated gene that encodes a fusion protein having the amino acid sequence of SEQ ID NO: 70.
2. A vector containing the DNA of SEQ ID NO: 71 encoding the ribonuclease of SEQ ID NO: 70.
Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jun 10, 2020
From: TAMIR BIOTECHNOLOGY, INC.
To: ORGENESIS INC.
Reel/Frame 052892/0702 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Mar 27, 2020
From: SAXENA, SHAILENDRA K.
To: ALFACELL CORPORATION
Reel/Frame 052241/0958 →
CHANGE OF NAME
Recorded Mar 27, 2020
From: ALFACELL CORPORATION
To: TAMIR BIOTECHNOLOGY, INC.
Reel/Frame 052251/0288 →
Continuity (3)